董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Roy Chin | 男 | Executive Chairman, Chief Executive Officer and Chairman of the Board | 52 | 未披露 | 未持股 | 2018-09-18 |
| Robyn Burrows Ownbey | 男 | Chief Technology Officer and Director | 32 | 未披露 | 未持股 | 2018-09-18 |
| William Enquist | 男 | Director | 61 | 未披露 | 未持股 | 2018-09-18 |
| Paul Arnold | 男 | Director | 57 | 未披露 | 未持股 | 2018-09-18 |
| Pat LaVecchia | 男 | Director | 51 | 未披露 | 未持股 | 2018-09-18 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Roy Chin | 男 | Executive Chairman, Chief Executive Officer and Chairman of the Board | 52 | 未披露 | 未持股 | 2018-09-18 |
| Andrew Rogers | 男 | President and Secretary | 27 | 未披露 | 未持股 | 2018-09-18 |
| George Oliva | 男 | Interim Chief Financial Officer | 57 | 未披露 | 未持股 | 2018-09-18 |
| Robyn Burrows Ownbey | 男 | Chief Technology Officer and Director | 32 | 未披露 | 未持股 | 2018-09-18 |
| Christie Wang | 女 | President, Global Business | 39 | 未披露 | 未持股 | 2018-09-18 |
| Eric Blossey | 男 | Chief Commercial Officer | 37 | 未披露 | 未持股 | 2018-09-18 |
董事简历
中英对照 | 中文 | 英文- Roy Chin
-
暂无中文简介
Roy Chin has served as our Executive Chairman, Chief Executive Officer and Chairman of the Board since March 2017. From 2014 to 2017 Roy was the co-Founder and a board member of Medika Healthcare, a cross-border medical device company. Medika is a medical device company focusing on developing and manufacturing a non-invasive glucose monitoring system. Prior to Medika, from 2006 to 2012 he was the Founder and CEO of SpineView, an endoscopic spinal company. Mr. Chin was not actively employed by any company between 2012 and 2014 as he focused on finding a medical technology innovation. From 1999 to 2004 Mr. Chin was Vice President of AFx, where he patented an endoscopic device to cure atrial fibrillation and trained more than 100 physicians in endoscopic procedures before AFx was acquired by Guidant in 2004. Prior to AFx, Mr. Chin was with CardioThoracic Systems “CTS”, a company developing stabilizer systems for minimally invasive coronary bypass surgery on the beating heart. CTS went public in 1996 and it was acquired by Guidant in 1999. Prior to that he was with Stryker Endoscopy since 1988 in various managerial and engineering capacities developing technologies for knee and shoulder arthroscopy, ENT, and general surgery. Mr. Chin holds a Bachelor of Science degree in Electrical Engineering from the University of Kansas, USA. -
暂无中文简介
- Roy Chin has served as our Executive Chairman, Chief Executive Officer and Chairman of the Board since March 2017. From 2014 to 2017 Roy was the co-Founder and a board member of Medika Healthcare, a cross-border medical device company. Medika is a medical device company focusing on developing and manufacturing a non-invasive glucose monitoring system. Prior to Medika, from 2006 to 2012 he was the Founder and CEO of SpineView, an endoscopic spinal company. Mr. Chin was not actively employed by any company between 2012 and 2014 as he focused on finding a medical technology innovation. From 1999 to 2004 Mr. Chin was Vice President of AFx, where he patented an endoscopic device to cure atrial fibrillation and trained more than 100 physicians in endoscopic procedures before AFx was acquired by Guidant in 2004. Prior to AFx, Mr. Chin was with CardioThoracic Systems “CTS”, a company developing stabilizer systems for minimally invasive coronary bypass surgery on the beating heart. CTS went public in 1996 and it was acquired by Guidant in 1999. Prior to that he was with Stryker Endoscopy since 1988 in various managerial and engineering capacities developing technologies for knee and shoulder arthroscopy, ENT, and general surgery. Mr. Chin holds a Bachelor of Science degree in Electrical Engineering from the University of Kansas, USA.
- Robyn Burrows Ownbey
-
暂无中文简介
Robyn Burrows Ownbey has served as our Chief Technology Officer and Director since March 2017. From May 2013 to February 2017 Mr. Ownbey was a Design Certification Engineer and Mechanical Engineer for Garmin. From February 2017 to July 2017 Mr. Ownbey, in addition to serving as our CTO, was a Mechanical Engineer at KCI Inc. where he helped his company’s client, Tesla, during the manufacture of the Model 3. Mr. Ownbey graduated from the University of Kansas in 2013 with a Bachelor of Science in Mechanical Engineering and a concentration in Biomechanics. -
暂无中文简介
- Robyn Burrows Ownbey has served as our Chief Technology Officer and Director since March 2017. From May 2013 to February 2017 Mr. Ownbey was a Design Certification Engineer and Mechanical Engineer for Garmin. From February 2017 to July 2017 Mr. Ownbey, in addition to serving as our CTO, was a Mechanical Engineer at KCI Inc. where he helped his company’s client, Tesla, during the manufacture of the Model 3. Mr. Ownbey graduated from the University of Kansas in 2013 with a Bachelor of Science in Mechanical Engineering and a concentration in Biomechanics.
- William Enquist
-
暂无中文简介
William Enquist has served as a member of the Board of Directors since August 2017. Since 2015 Mr. Enquist has served on the Board of EndoChoice, Inc., a medical technology company which focuses on the manufacturing and commercialization of platform technologies including endoscopic imaging systems, devices, and infection control products and pathology services. Mr. Enquist was elected Chairman of the Board of EndoChoice in 2016. In 2014 and 2015 Mr. Enquist served as a Board Member of Firefly Medical, Inc., a company which develops and produces transformative patient mobility solutions. From 1986 to 2014 he served in various roles for Stryker Corporation, a leading medical technology company. From 1995-2013 he was President of Stryker’s Global Endoscopy Division. Mr. Enquist received his B.B.A. from the University of San Diego in 1978. -
暂无中文简介
- William Enquist has served as a member of the Board of Directors since August 2017. Since 2015 Mr. Enquist has served on the Board of EndoChoice, Inc., a medical technology company which focuses on the manufacturing and commercialization of platform technologies including endoscopic imaging systems, devices, and infection control products and pathology services. Mr. Enquist was elected Chairman of the Board of EndoChoice in 2016. In 2014 and 2015 Mr. Enquist served as a Board Member of Firefly Medical, Inc., a company which develops and produces transformative patient mobility solutions. From 1986 to 2014 he served in various roles for Stryker Corporation, a leading medical technology company. From 1995-2013 he was President of Stryker’s Global Endoscopy Division. Mr. Enquist received his B.B.A. from the University of San Diego in 1978.
- Paul Arnold
-
暂无中文简介
Paul Arnold has served as a member of the Board of Directors since August 2017. Since 2010 Dr. Arnold has served as a Professor and Vice Chair of Research in the Department of Neurosurgery at the University of Kansas Medical Center and is also a special faculty member in the Department of Preventive Medicine and Public Health. He also serves as a Distinguished Professor of Orthopedics at the Southwest Hospital of the Third Military Medical University in Chongqing, China. Dr. Arnold has published more than 250 articles in peer-reviewed journals and has published more than 30 book chapters, more than 200 abstracts, and more than 35 other scholarly publications. Dr. Arnold sits on the Editorial Board of the following publications: The Spine Journal; Spine; Journal of Neurosurgery: Spine; Global Spine Journal; Surgical Neurology International; Clinical Spine Surgery; Journal of Spinal Cord Medicine and Public Library of Science One. He is professionally affiliated with many neurological and spinal organizations, including: AOSpine North America, AOSpine International, American Association of Neurological Surgeons, Cervical Spine Research Society, and Lumbar Spine Research Society. Dr. Arnold received his B.S. from the University of Illinois, where he also attended medical school. -
暂无中文简介
- Paul Arnold has served as a member of the Board of Directors since August 2017. Since 2010 Dr. Arnold has served as a Professor and Vice Chair of Research in the Department of Neurosurgery at the University of Kansas Medical Center and is also a special faculty member in the Department of Preventive Medicine and Public Health. He also serves as a Distinguished Professor of Orthopedics at the Southwest Hospital of the Third Military Medical University in Chongqing, China. Dr. Arnold has published more than 250 articles in peer-reviewed journals and has published more than 30 book chapters, more than 200 abstracts, and more than 35 other scholarly publications. Dr. Arnold sits on the Editorial Board of the following publications: The Spine Journal; Spine; Journal of Neurosurgery: Spine; Global Spine Journal; Surgical Neurology International; Clinical Spine Surgery; Journal of Spinal Cord Medicine and Public Library of Science One. He is professionally affiliated with many neurological and spinal organizations, including: AOSpine North America, AOSpine International, American Association of Neurological Surgeons, Cervical Spine Research Society, and Lumbar Spine Research Society. Dr. Arnold received his B.S. from the University of Illinois, where he also attended medical school.
- Pat LaVecchia
-
Pat LaVecchia，2005年9月起，他担任公司的董事会成员；2009年9月起，担任副主席。2005年9月至2007年11月，他担任公司秘书。2007年起，他担任商业银行业务与投资公司LaVecchia Capital LLC的创始人和管理合伙人，在华尔街有20多年工作经验。他成立并经营多个华尔街集团，在资本市场有丰富的专业知识，包括首次公开募股、二次募股、私营公司融资、上市公司私人股权投资以及在许多合并、收购、发行债券时直接销售和高产交易中起着领导作用。成立LaVecchia Capital之前，他经营大型华尔街公司的多个集团，包括：1994至1997年，担任Bear, Stearns & Company的总经理和私募股权配售部门主管；1997至2000年，担任Credit Suisse First Boston的全球私人公司股票配售部门主管；2001至2003年，担任Legg Mason Wood Walker, Inc的总经理和私募股权与赞助商部门主管；2003至2005年，担任Viant Group的创始人之一和管理合伙人；2005至2007年，担任FTN Midwest Securities Corp的总经理和资本市场主管。2000至2001年，他就职于战略风险资本公司Hawk Holdings。他在克拉克大学（Clark University）（被选入美国大学优秀生全国荣誉组织）以优异成绩获得文学士学位，在宾夕法尼亚大学沃顿学院（University of Pennsylvania）获得工商管理硕士学位，专业为金融，关注战略规划。他目前还担任Premiere Opportunities Group, Inc. (PPBL, OTC) 的联合主席和Sulla Global Partners的管理合伙人。他还是多个咨询委员会和非营利董事会成员。
Pat LaVecchia has served as a member of the board of directors since 2011. Mr. LaVecchia is the CEO of Oasis Pro Markets, a broker dealer. Previously he had been a founding principal and Managing Member of LaVecchia Capital LLC “LaVecchia Capital”, a broker dealer, since 2009 and has over 25+ years of experience in the financial industry. Mr. LaVecchia has built and run several major Wall Street groups and has extensive expertise in capital markets, including initial public offerings, secondary offerings, raising capital for private companies and PIPEs as well as playing the leading role in numerous mergers, acquisitions, private placements and high yield transactions. Prior to forming LaVecchia Capital, Mr. LaVecchia ran several groups at major firms including: Managing Director and Head of the Private Equity Placement Group at Bear, Stearns & Company 1994 to 1997; Group Head of Global Private Corporate Equity Placements at Credit Suisse First Boston 1997 to 2000; Managing Director and Group Head of the Private Finance and Sponsors Group at Legg Mason Wood Walker, Inc (2001 to 2003); co-founder and Managing Partner of Viant Group (2003-2005) and Managing Director and Head of Capital Markets at FTN Midwest Securities Corp. (2005 to 2007). Mr. LaVecchia received his B.A., magna cum laude (and elected to Phi Beta Kappa), from Clark University and an M.B.A. from The Wharton School of the University of Pennsylvania with a major in Finance and a concentration in Strategic Planning. In the past, Mr. LaVecchia has served on several public company boards, including as Vice Chairman of InfuSystems, Inc. (INFU). Mr. LaVecchia is also currently a managing partner of Sapphire Capital Management. Mr. LaVecchia also sits on several private company boards, advisory boards and non-profit boards. - Pat LaVecchia，2005年9月起，他担任公司的董事会成员；2009年9月起，担任副主席。2005年9月至2007年11月，他担任公司秘书。2007年起，他担任商业银行业务与投资公司LaVecchia Capital LLC的创始人和管理合伙人，在华尔街有20多年工作经验。他成立并经营多个华尔街集团，在资本市场有丰富的专业知识，包括首次公开募股、二次募股、私营公司融资、上市公司私人股权投资以及在许多合并、收购、发行债券时直接销售和高产交易中起着领导作用。成立LaVecchia Capital之前，他经营大型华尔街公司的多个集团，包括：1994至1997年，担任Bear, Stearns & Company的总经理和私募股权配售部门主管；1997至2000年，担任Credit Suisse First Boston的全球私人公司股票配售部门主管；2001至2003年，担任Legg Mason Wood Walker, Inc的总经理和私募股权与赞助商部门主管；2003至2005年，担任Viant Group的创始人之一和管理合伙人；2005至2007年，担任FTN Midwest Securities Corp的总经理和资本市场主管。2000至2001年，他就职于战略风险资本公司Hawk Holdings。他在克拉克大学（Clark University）（被选入美国大学优秀生全国荣誉组织）以优异成绩获得文学士学位，在宾夕法尼亚大学沃顿学院（University of Pennsylvania）获得工商管理硕士学位，专业为金融，关注战略规划。他目前还担任Premiere Opportunities Group, Inc. (PPBL, OTC) 的联合主席和Sulla Global Partners的管理合伙人。他还是多个咨询委员会和非营利董事会成员。
- Pat LaVecchia has served as a member of the board of directors since 2011. Mr. LaVecchia is the CEO of Oasis Pro Markets, a broker dealer. Previously he had been a founding principal and Managing Member of LaVecchia Capital LLC “LaVecchia Capital”, a broker dealer, since 2009 and has over 25+ years of experience in the financial industry. Mr. LaVecchia has built and run several major Wall Street groups and has extensive expertise in capital markets, including initial public offerings, secondary offerings, raising capital for private companies and PIPEs as well as playing the leading role in numerous mergers, acquisitions, private placements and high yield transactions. Prior to forming LaVecchia Capital, Mr. LaVecchia ran several groups at major firms including: Managing Director and Head of the Private Equity Placement Group at Bear, Stearns & Company 1994 to 1997; Group Head of Global Private Corporate Equity Placements at Credit Suisse First Boston 1997 to 2000; Managing Director and Group Head of the Private Finance and Sponsors Group at Legg Mason Wood Walker, Inc (2001 to 2003); co-founder and Managing Partner of Viant Group (2003-2005) and Managing Director and Head of Capital Markets at FTN Midwest Securities Corp. (2005 to 2007). Mr. LaVecchia received his B.A., magna cum laude (and elected to Phi Beta Kappa), from Clark University and an M.B.A. from The Wharton School of the University of Pennsylvania with a major in Finance and a concentration in Strategic Planning. In the past, Mr. LaVecchia has served on several public company boards, including as Vice Chairman of InfuSystems, Inc. (INFU). Mr. LaVecchia is also currently a managing partner of Sapphire Capital Management. Mr. LaVecchia also sits on several private company boards, advisory boards and non-profit boards.
高管简历
中英对照 | 中文 | 英文- Roy Chin
- 暂无中文简介
Roy Chin has served as our Executive Chairman, Chief Executive Officer and Chairman of the Board since March 2017. From 2014 to 2017 Roy was the co-Founder and a board member of Medika Healthcare, a cross-border medical device company. Medika is a medical device company focusing on developing and manufacturing a non-invasive glucose monitoring system. Prior to Medika, from 2006 to 2012 he was the Founder and CEO of SpineView, an endoscopic spinal company. Mr. Chin was not actively employed by any company between 2012 and 2014 as he focused on finding a medical technology innovation. From 1999 to 2004 Mr. Chin was Vice President of AFx, where he patented an endoscopic device to cure atrial fibrillation and trained more than 100 physicians in endoscopic procedures before AFx was acquired by Guidant in 2004. Prior to AFx, Mr. Chin was with CardioThoracic Systems “CTS”, a company developing stabilizer systems for minimally invasive coronary bypass surgery on the beating heart. CTS went public in 1996 and it was acquired by Guidant in 1999. Prior to that he was with Stryker Endoscopy since 1988 in various managerial and engineering capacities developing technologies for knee and shoulder arthroscopy, ENT, and general surgery. Mr. Chin holds a Bachelor of Science degree in Electrical Engineering from the University of Kansas, USA. - 暂无中文简介
- Roy Chin has served as our Executive Chairman, Chief Executive Officer and Chairman of the Board since March 2017. From 2014 to 2017 Roy was the co-Founder and a board member of Medika Healthcare, a cross-border medical device company. Medika is a medical device company focusing on developing and manufacturing a non-invasive glucose monitoring system. Prior to Medika, from 2006 to 2012 he was the Founder and CEO of SpineView, an endoscopic spinal company. Mr. Chin was not actively employed by any company between 2012 and 2014 as he focused on finding a medical technology innovation. From 1999 to 2004 Mr. Chin was Vice President of AFx, where he patented an endoscopic device to cure atrial fibrillation and trained more than 100 physicians in endoscopic procedures before AFx was acquired by Guidant in 2004. Prior to AFx, Mr. Chin was with CardioThoracic Systems “CTS”, a company developing stabilizer systems for minimally invasive coronary bypass surgery on the beating heart. CTS went public in 1996 and it was acquired by Guidant in 1999. Prior to that he was with Stryker Endoscopy since 1988 in various managerial and engineering capacities developing technologies for knee and shoulder arthroscopy, ENT, and general surgery. Mr. Chin holds a Bachelor of Science degree in Electrical Engineering from the University of Kansas, USA.
- Andrew Rogers
- 暂无中文简介
Andrew Rogers has served as our President and Secretary since March 2017. From 2013 to 2017 Mr. Rogers was a Global Product Engineer at Emerson Automation Solutions. Mr. Rogers attended the University of Kansas from 2009 to 2013 where he graduated with a Bachelors in Mechanical Engineering with a concentration in biomechanics. - 暂无中文简介
- Andrew Rogers has served as our President and Secretary since March 2017. From 2013 to 2017 Mr. Rogers was a Global Product Engineer at Emerson Automation Solutions. Mr. Rogers attended the University of Kansas from 2009 to 2013 where he graduated with a Bachelors in Mechanical Engineering with a concentration in biomechanics.
- George Oliva
George Oliva自2019年9月9日起担任秘书兼首席财务官。Oliva先生自2019年5月起担任执行官咨询服务提供商Hardesty，LLC的合伙人，通过该公司向全国的上市公司和私人公司提供财务咨询服务。从2019年6月至9月，Oliva先生担任科学仪器业务Full Spectrum Analytics的临时首席财务官，在那里他促成了一笔出售给私募股权公司的交易。从2018年8月至2019年4月，奥利瓦先生担任加州医疗设备制造商SpineEX，Inc.的临时首席财务官，负责管理该公司的财务，人力资源和信息技术部门。从2018年6月到2018年8月，他曾担任GameWorks公司（家庭娱乐连锁公司）的财务Vice President，在那里他制定了一项重组公司业务的计划，涉及一家贷款机构的收购。从2017年3月至2018年6月，Oliva先生担任音频公司EVA Automation的财务总监，在那里他实施了与1.8亿美元收购相关的购买会计。2016年8月至2017年3月，奥利瓦先生担任跨国软件和工程服务公司PDFSolutions，Inc.的临时财务Vice President，管理该公司的财务和会计部门。2014年3月至2016年6月，Oliva先生担任Tegile Systems（总部位于加利福尼亚州的闪存阵列制造商）的公司财务总监。2014年之前，Oliva先生曾担任加州其他多家公司的临时首席财务官和财务Vice President以及公司财务总监。他曾担任Penguin Computing公司的首席财务官（从2009年到2013年），在那里他曾领导他们度过一个快速增长的时期，两次入选《硅谷商业杂志》（the Silicon Valley Business Journal）的增长最快的私人公司名单。任职Penguin公司之前，他曾担任StorCard公司和Hammer Storage Solutions公司的首席财务官，都从事数据存储行业。他也曾担任Conner Peripherals公司和Read-Rite公司的全球运营总会计师，在那里他负责多个国际地点的业务规划、产品成本和财务分析，两家公司的年收入都超过10亿美元。Oliva先生在当时领先的公共会计师事务所Arthur Andersen&Co.开始他的职业生涯。Oliva先生是一名注册会计师，不活跃，并持有加州大学伯克利分校Walter A.Haas商学院的工商管理学士学位。
George Oliva joined the RYVYL team in October 2023 as Chief Financial Officer, has served as a Director since September 2025, has served as Interim Chief Executive Officer since October 31, 2025, and has over 30 years as a senior finance professional, with a background in corporate finance, treasury, financial planning and analysis, international tax, and strategic planning. Prior to joining RYVYL, he was Chief Financial Officer and Corporate Secretary for WiSA Technologies ("WiSA") since 2019. Prior to WiSA, he provided financial consulting services to public and private companies nationwide. He was also a partner with Hardesty LLC, a national executive services firm. Mr. Oliva has held several interim positions with a variety of clients that included a scientific instruments biness acquired by a private equity firm, a medical device manufacturer preparing for an IPO, an audio company merger and a yield improvement software company implementing a world wide ERP system. Mr. Oliva was CFO of Penguin Computing from 2009 through 2013, where he played a leading role in guiding them through a period of rapid growth, twice making the Silicon Valley Biness Jnal's list of fastest growing private companies. Prior to Penguin, he was CFO of StreamLogic, a public company doing biness as Hammer Storage Solutions, where he navigated its going private transaction. Prior to serving in such roles, Mr. Oliva was responsible for financial planning and analysis and operational support as the operations controller for Conner Peripherals and at Read Rite Corporation, both exceeding a billion of revenue in the data storage indtry. Mr. Oliva began his career in auditing with Arthur Andersen & Co., a leading public accounting firm. Mr. Oliva is a certified public accountant, currently inactive stat. He earned a B.S. degree in Biness Administration from U.C. Berkeley with a dual emphasis in Accounting and Finance.- George Oliva自2019年9月9日起担任秘书兼首席财务官。Oliva先生自2019年5月起担任执行官咨询服务提供商Hardesty，LLC的合伙人，通过该公司向全国的上市公司和私人公司提供财务咨询服务。从2019年6月至9月，Oliva先生担任科学仪器业务Full Spectrum Analytics的临时首席财务官，在那里他促成了一笔出售给私募股权公司的交易。从2018年8月至2019年4月，奥利瓦先生担任加州医疗设备制造商SpineEX，Inc.的临时首席财务官，负责管理该公司的财务，人力资源和信息技术部门。从2018年6月到2018年8月，他曾担任GameWorks公司（家庭娱乐连锁公司）的财务Vice President，在那里他制定了一项重组公司业务的计划，涉及一家贷款机构的收购。从2017年3月至2018年6月，Oliva先生担任音频公司EVA Automation的财务总监，在那里他实施了与1.8亿美元收购相关的购买会计。2016年8月至2017年3月，奥利瓦先生担任跨国软件和工程服务公司PDFSolutions，Inc.的临时财务Vice President，管理该公司的财务和会计部门。2014年3月至2016年6月，Oliva先生担任Tegile Systems（总部位于加利福尼亚州的闪存阵列制造商）的公司财务总监。2014年之前，Oliva先生曾担任加州其他多家公司的临时首席财务官和财务Vice President以及公司财务总监。他曾担任Penguin Computing公司的首席财务官（从2009年到2013年），在那里他曾领导他们度过一个快速增长的时期，两次入选《硅谷商业杂志》（the Silicon Valley Business Journal）的增长最快的私人公司名单。任职Penguin公司之前，他曾担任StorCard公司和Hammer Storage Solutions公司的首席财务官，都从事数据存储行业。他也曾担任Conner Peripherals公司和Read-Rite公司的全球运营总会计师，在那里他负责多个国际地点的业务规划、产品成本和财务分析，两家公司的年收入都超过10亿美元。Oliva先生在当时领先的公共会计师事务所Arthur Andersen&Co.开始他的职业生涯。Oliva先生是一名注册会计师，不活跃，并持有加州大学伯克利分校Walter A.Haas商学院的工商管理学士学位。
- George Oliva joined the RYVYL team in October 2023 as Chief Financial Officer, has served as a Director since September 2025, has served as Interim Chief Executive Officer since October 31, 2025, and has over 30 years as a senior finance professional, with a background in corporate finance, treasury, financial planning and analysis, international tax, and strategic planning. Prior to joining RYVYL, he was Chief Financial Officer and Corporate Secretary for WiSA Technologies ("WiSA") since 2019. Prior to WiSA, he provided financial consulting services to public and private companies nationwide. He was also a partner with Hardesty LLC, a national executive services firm. Mr. Oliva has held several interim positions with a variety of clients that included a scientific instruments biness acquired by a private equity firm, a medical device manufacturer preparing for an IPO, an audio company merger and a yield improvement software company implementing a world wide ERP system. Mr. Oliva was CFO of Penguin Computing from 2009 through 2013, where he played a leading role in guiding them through a period of rapid growth, twice making the Silicon Valley Biness Jnal's list of fastest growing private companies. Prior to Penguin, he was CFO of StreamLogic, a public company doing biness as Hammer Storage Solutions, where he navigated its going private transaction. Prior to serving in such roles, Mr. Oliva was responsible for financial planning and analysis and operational support as the operations controller for Conner Peripherals and at Read Rite Corporation, both exceeding a billion of revenue in the data storage indtry. Mr. Oliva began his career in auditing with Arthur Andersen & Co., a leading public accounting firm. Mr. Oliva is a certified public accountant, currently inactive stat. He earned a B.S. degree in Biness Administration from U.C. Berkeley with a dual emphasis in Accounting and Finance.
- Robyn Burrows Ownbey
- 暂无中文简介
Robyn Burrows Ownbey has served as our Chief Technology Officer and Director since March 2017. From May 2013 to February 2017 Mr. Ownbey was a Design Certification Engineer and Mechanical Engineer for Garmin. From February 2017 to July 2017 Mr. Ownbey, in addition to serving as our CTO, was a Mechanical Engineer at KCI Inc. where he helped his company’s client, Tesla, during the manufacture of the Model 3. Mr. Ownbey graduated from the University of Kansas in 2013 with a Bachelor of Science in Mechanical Engineering and a concentration in Biomechanics. - 暂无中文简介
- Robyn Burrows Ownbey has served as our Chief Technology Officer and Director since March 2017. From May 2013 to February 2017 Mr. Ownbey was a Design Certification Engineer and Mechanical Engineer for Garmin. From February 2017 to July 2017 Mr. Ownbey, in addition to serving as our CTO, was a Mechanical Engineer at KCI Inc. where he helped his company’s client, Tesla, during the manufacture of the Model 3. Mr. Ownbey graduated from the University of Kansas in 2013 with a Bachelor of Science in Mechanical Engineering and a concentration in Biomechanics.
- Christie Wang
- 暂无中文简介
Christie Wang has served as our President, Global Business since September 2017. From 2014 to 2017 Christie was the co-Founder and a board member of Medika Healthcare, a cross-border medical device company. Medika is a medical device company focusing on developing and manufacturing a non-invasive glucose monitoring system. Prior to Medika, from 2014 to 2015 Christie was CEO of Unisource, Inc. USA, a cross-border venture firm and industrial platform. Prior to this, from 2010 to 2014 Christie worked in the legal department at Hewlett Packard Company, Palo Alto, CA focusing on legal, compliance and business issues between U.S., European and Asian markets. Christie earned a J.D. from Northwestern University School of Law and a B.A. from Sun Yat-Sen University in China. In 2016 she also served as mentor for the Stanford University Technology Innovation. Christie was born and raised in China and speaks Chinese and Cantonese. She was awarded the Most Outstanding Overseas Youth Chinese by the State Council of PRC in 2015. - 暂无中文简介
- Christie Wang has served as our President, Global Business since September 2017. From 2014 to 2017 Christie was the co-Founder and a board member of Medika Healthcare, a cross-border medical device company. Medika is a medical device company focusing on developing and manufacturing a non-invasive glucose monitoring system. Prior to Medika, from 2014 to 2015 Christie was CEO of Unisource, Inc. USA, a cross-border venture firm and industrial platform. Prior to this, from 2010 to 2014 Christie worked in the legal department at Hewlett Packard Company, Palo Alto, CA focusing on legal, compliance and business issues between U.S., European and Asian markets. Christie earned a J.D. from Northwestern University School of Law and a B.A. from Sun Yat-Sen University in China. In 2016 she also served as mentor for the Stanford University Technology Innovation. Christie was born and raised in China and speaks Chinese and Cantonese. She was awarded the Most Outstanding Overseas Youth Chinese by the State Council of PRC in 2015.
- Eric Blossey
- 暂无中文简介
Eric Blossey has served as our Chief Commercial Officer since October 2017. Eric began his entrepreneurial career while attending college at Arizona State University in 2003. He co-founded a security and asset protection company, Job Site Security and Protection JSSP in 2001. Eric launched the core of this business and branched into complementary services, which included site management, fire protection, and real estate development. From 2009 to 2015 Eric transitioned to the medical device industry and began working with a small spinal deformity company, Medicrea USA. During his tenure, Eric contributed to the design process for three new spinal devices. Over the last three years, Eric has also worked in spinal device sales roles with the following companies: DePuy Synthes Spine -2015 Xtant Medical 2016-2017 and Spineart USA -2017. - 暂无中文简介
- Eric Blossey has served as our Chief Commercial Officer since October 2017. Eric began his entrepreneurial career while attending college at Arizona State University in 2003. He co-founded a security and asset protection company, Job Site Security and Protection JSSP in 2001. Eric launched the core of this business and branched into complementary services, which included site management, fire protection, and real estate development. From 2009 to 2015 Eric transitioned to the medical device industry and began working with a small spinal deformity company, Medicrea USA. During his tenure, Eric contributed to the design process for three new spinal devices. Over the last three years, Eric has also worked in spinal device sales roles with the following companies: DePuy Synthes Spine -2015 Xtant Medical 2016-2017 and Spineart USA -2017.